§ Funding Round
Series A funding round for NGM Biopharmaceuticals raising $120M in July 2024
Series A funding round for NGM Biopharmaceuticals raising $120M in July 2024
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
The Column GroupLEAD | Organization | — |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$335M
Top Valuation
-
NGM Biopharmaceuticals raised $120M in a Series A round.
The round was announced on 07/01/24.
The round was led by The Column Group.
